Global Bone Morphogenetic Protein (BMP) Market Growth 2025-2031

The global Bone Morphogenetic Protein (BMP) market size is predicted to grow from US$ 687 million in 2025 to US$ 1182 million in 2031; it is expected to grow at a CAGR of 9.5% from 2025 to 2031.

Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.

Human recombinant BMP7 has surgical uses and was originally marketed under the brand name OP1 (Olympus Biotech, who bought it from Stryker). It can be used to aid in the fusion of vertebral bodies to prevent neurologic trauma. rhBMP-7 has withdrawn off the market. rhBMP-4 and rhBMP-6 do not have commercial product launched. Therefore, in this report, we only study the rhBMP-2.

Bone Morphogenetic Protein 2 (BMP-2) is a member of the bone morphogenetic protein family, a group of proteins that play a crucial role in bone and cartilage formation during embryonic development and adult tissue repair. BMP-2 is known for its potent osteoinductive properties, meaning it has the ability to stimulate the differentiation of mesenchymal stem cells into osteoblasts, the cells responsible for bone formation. This property makes BMP-2 a valuable therapeutic agent in orthopedic and dental surgeries, particularly in procedures aimed at promoting bone regeneration and spinal fusion.

The global core manufacturers of Bone Morphogenetic Protein (BMP) include Medtronic, Jiuyuan Gene Engineering and Cellumed. The top three companies have a market share of about 99%. North America is the largest global market for Bone Morphogenetic Protein (BMP) with a market share of approximately 69%, followed by Asia Pacific and Europe with a market share of 19% and 9%, respectively. In terms of application, Spinal Fusion is the largest downstream segment, accounting for approximately 73% of the market.

LP Information, Inc. (LPI) ' newest research report, the “Bone Morphogenetic Protein (BMP) Industry Forecast” looks at past sales and reviews total world Bone Morphogenetic Protein (BMP) sales in 2024, providing a comprehensive analysis by region and market sector of projected Bone Morphogenetic Protein (BMP) sales for 2025 through 2031. With Bone Morphogenetic Protein (BMP) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bone Morphogenetic Protein (BMP) industry.

This Insight Report provides a comprehensive analysis of the global Bone Morphogenetic Protein (BMP) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bone Morphogenetic Protein (BMP) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bone Morphogenetic Protein (BMP) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bone Morphogenetic Protein (BMP) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bone Morphogenetic Protein (BMP).

This report presents a comprehensive overview, market shares, and growth opportunities of Bone Morphogenetic Protein (BMP) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Sponge Carrier
Hydroxyapatite Carrier

Segmentation by Application:
Spinal Fusion
Trauma Surgery
Oral Maxillofacial Surgery
Reconstructive

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Medtronic
Jiuyuan Gene Engineering
Cellumed

Key Questions Addressed in this Report

What is the 10-year outlook for the global Bone Morphogenetic Protein (BMP) market?

What factors are driving Bone Morphogenetic Protein (BMP) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Bone Morphogenetic Protein (BMP) market opportunities vary by end market size?

How does Bone Morphogenetic Protein (BMP) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.